These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16033970)
41. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541 [TBL] [Abstract][Full Text] [Related]
42. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Wang Y; Tao L; Mitchell E; Bravery C; Berlingieri P; Armstrong P; Vaughan R; Underwood J; Lehner T Nat Med; 1999 Sep; 5(9):1004-9. PubMed ID: 10470076 [TBL] [Abstract][Full Text] [Related]
43. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. Velu V; Kannanganat S; Ibegbu C; Chennareddi L; Villinger F; Freeman GJ; Ahmed R; Amara RR J Virol; 2007 Jun; 81(11):5819-28. PubMed ID: 17376899 [TBL] [Abstract][Full Text] [Related]
44. Dualtropic CXCR6/CCR5 Simian Immunodeficiency Virus (SIV) Infection of Sooty Mangabey Primary Lymphocytes: Distinct Coreceptor Use in Natural versus Pathogenic Hosts of SIV. Elliott ST; Wetzel KS; Francella N; Bryan S; Romero DC; Riddick NE; Shaheen F; Vanderford T; Derdeyn CA; Silvestri G; Paiardini M; Collman RG J Virol; 2015 Sep; 89(18):9252-61. PubMed ID: 26109719 [TBL] [Abstract][Full Text] [Related]
45. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques. Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918 [TBL] [Abstract][Full Text] [Related]
46. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. Kaur A; Hale CL; Ramanujan S; Jain RK; Johnson RP J Virol; 2000 Sep; 74(18):8413-24. PubMed ID: 10954541 [TBL] [Abstract][Full Text] [Related]
47. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. Sugimoto C; Tadakuma K; Otani I; Moritoyo T; Akari H; Ono F; Yoshikawa Y; Sata T; Izumo S; Mori K J Virol; 2003 Apr; 77(7):4169-80. PubMed ID: 12634375 [TBL] [Abstract][Full Text] [Related]
48. Differences between T cell epitopes recognized after immunization and after infection. Vogel TU; Horton H; Fuller DH; Carter DK; Vielhuber K; O'Connor DH; Shipley T; Fuller J; Sutter G; Erfle V; Wilson N; Picker LJ; Watkins DI J Immunol; 2002 Oct; 169(8):4511-21. PubMed ID: 12370388 [TBL] [Abstract][Full Text] [Related]
49. Comparison of susceptibility to SIVmac239 infection between CD4(+) and CD4(+)8(+) T cells. Takahashi M; Ido E; Uesaka H; Fukushima T; Ibuki K; Miura T; Hayami M; Takahashi H Arch Virol; 2005 Aug; 150(8):1517-28. PubMed ID: 15841338 [TBL] [Abstract][Full Text] [Related]
50. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150 [TBL] [Abstract][Full Text] [Related]
51. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694 [TBL] [Abstract][Full Text] [Related]
52. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Gauduin MC; Glickman RL; Ahmad S; Yilma T; Johnson RP Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14031-6. PubMed ID: 10570193 [TBL] [Abstract][Full Text] [Related]
53. CD8+ T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. Monceaux V; Viollet L; Petit F; Ho Tsong Fang R; Cumont MC; Zaunders J; Hurtrel B; Estaquier J J Immunol; 2005 Jun; 174(11):6898-908. PubMed ID: 15905532 [TBL] [Abstract][Full Text] [Related]
54. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections. Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799 [TBL] [Abstract][Full Text] [Related]
55. Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virus. Stolte-Leeb N; Sauermann U; Norley S; Fagrouch Z; Heeney J; Franz M; Hunsmann G; Stahl-Hennig C Viral Immunol; 2006; 19(3):448-57. PubMed ID: 16987063 [TBL] [Abstract][Full Text] [Related]
56. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Lehner T; Wang Y; Cranage M; Bergmeier LA; Mitchell E; Tao L; Hall G; Dennis M; Cook N; Jones I; Doyle C Dev Biol Stand; 1998; 92():225-35. PubMed ID: 9554279 [TBL] [Abstract][Full Text] [Related]
57. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy. Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756 [TBL] [Abstract][Full Text] [Related]
58. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518 [TBL] [Abstract][Full Text] [Related]
59. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116 [TBL] [Abstract][Full Text] [Related]
60. Macrophage-derived simian immunodeficiency virus exhibits enhanced infectivity by comparison with T-cell-derived virus. Gaskill PJ; Zandonatti M; Gilmartin T; Head SR; Fox HS J Virol; 2008 Feb; 82(3):1615-21. PubMed ID: 18045942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]